KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Regeneron Pharmaceuticals (REGN) Shares Repurchased (2018 - 2025)

Regeneron Pharmaceuticals (REGN) has 8 years of Shares Repurchased data on record, last reported at $671.7 million in Q4 2025.

  • For Q4 2025, Shares Repurchased fell 30.97% year-over-year to $671.7 million; the TTM value through Dec 2025 reached $3.4 billion, up 32.09%, while the annual FY2025 figure was $3.4 billion, 32.09% up from the prior year.
  • Shares Repurchased reached $671.7 million in Q4 2025 per REGN's latest filing, up from $664.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $1.1 billion in Q2 2025 and bottomed at $289.0 million in Q4 2023.
  • Average Shares Repurchased over 5 years is $627.4 million, with a median of $664.0 million recorded in 2025.
  • Peak YoY movement for Shares Repurchased: crashed 59.01% in 2024, then soared 257.5% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $306.9 million in 2021, then soared by 40.47% to $431.1 million in 2022, then tumbled by 32.96% to $289.0 million in 2023, then skyrocketed by 236.68% to $973.0 million in 2024, then crashed by 30.97% to $671.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $671.7 million in Q4 2025, $664.0 million in Q3 2025, and $1.1 billion in Q2 2025.